Effects of dabigatran in vitro on thrombin biomarkers by calibrated automated thrombography in patients after ischemic stroke

Journal of Thrombosis and Thrombolysis

Volumn 33, Issue 1, 2012, Pages 22-27

  Serebruany, Victor ^a,b   Sani, Yanti ^c   Lynch, Donald ^a   Schevchuck, Alex ^d   Svetlov, Stan ^e   Fong, Alan ^c   Thevathasan, Lionel ^a   Hanley, Dan ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b HeartDrug Research Laboratories   (United States)

^c SARAWAK GENERAL HOSPITAL   (Malaysia)

^d UNIVERSITY OF NEW MEXICO   (United States)

^e Banyan Biomarkers   (United States)

Author keywords

Dabigatran; In vitro; Thrombin

Indexed keywords

BIOLOGICAL MARKER; DABIGATRAN; THROMBIN;

AGED; ARTICLE; BLOOD CLOTTING PARAMETERS; BLOOD SAMPLING; BRAIN ISCHEMIA; CLINICAL ARTICLE; CONCENTRATION RESPONSE; FEMALE; HEMATOLOGICAL PROCEDURES; HUMAN; IN VITRO STUDY; MALE; PRIORITY JOURNAL; THROMBIN SYNTHESIS; THROMBOCYTE POOR PLASMA; THROMBOGRAPHY; TIME;

AGED; AUTOMATION; BENZIMIDAZOLES; BETA-ALANINE; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; CALIBRATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; STROKE; THROMBIN;

EID: 84858864730     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-011-0654-x     Document Type: Article

References (24)

1. Hauel NH, Nar H, Priepke H, Ries U, Stassen JM, Wienen W (2002) Structure-based design of novel potent nonpeptide thrombin inhibitors. J Med Chem 45:1757-1766 (Pubitemid 34415371)
2. Ezekowitz MD, Reilly PA, Nehmiz G, Simmers TA, Nagarakanti R, Parcham-Azad K et al (2007) Dabigatran with or without concomitant aspirin compared with warfarin alone in patients with nonvalvular atrial fibrillation (PETRO Study). Am J Cardiol 100:1419-1426 (Pubitemid 47576022)
3. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A et al (2009) Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361:1139-1151
4. Siddiqui FM, Qureshi AI (2010) Dabigatran etexilate, a new oral direct thrombin inhibitor, for stroke prevention in patients with atrial fibrillation. Expert Opin Pharmacother 11:1403-1411
5. Stangier J (2008) Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate. Clin Pharmacokinet 47:285-295
6. Bode W (2007) Structure and interaction modes of thrombin. Blood Cells Mol Dis 36:122-130
7. Wolberg AS (2007) Thrombin generation and fibrin clot structure. Blood Rev 21:131-142
8. De Cristofaro R, De Candia E (2004) Thrombin domains: structure, function and interaction with platelet receptors. J Thromb Thrombolysis 15:151-163
9. Lockard MM, Witkowski S, Jenkins NT, Spangenburg EE, Obisesan TO, Hagberg JM (2010) Thrombin and exercise similarly influence expression of cell cycle genes in cultured putative endothelial progenitor cells. J Appl Physiol 108:1682-1690
10. Sossdorf M, König V, Gummert J, Marx G, Lósche W (2008) Correlations between platelet-derived microvesicles and thrombin generation in patients with coronary artery disease. Platelets 19:476-477
11. Kang DW, Yoo SH, Chun S, Kwon KY, Kwon SU, Koh JY, Kim JS (2009) Inflammatory and hemostatic biomarkers associated with early recurrent ischemic lesions in acute ischemic stroke. Stroke 40:1653-1658
12. Hemker HC, Giesen P, Al Dieri R, Regnault V, de Smed E, Wagenvoord R et al (2002) The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability. Pathophysiol Haemost Thromb 32:249-253 (Pubitemid 37490547)
13. Hemker HC, Giesen P, Al Dieri R, Regnault V, de Smedt E, Wagenvoord R et al (2003) Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 33:4-15 (Pubitemid 37449290)
14. Luddington R, Baglin T (2004) Clinical measurement of thrombin generation by calibrated automated thrombography requires contact factor inhibition. J Thromb Haemost 2:1954-1959 (Pubitemid 40192749)
15. Ahrens I, Lip GY, Peter K (2010) New oral anticoagulant drugs in cardiovascular disease. Thromb Haemost 104:49-60
16. van Ryn J, Stangier J, Haertter S, Liesenfeld KH, Wienen W, Feuring M, Clemens A (2010) Dabigatran etexilate-a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity. Thromb Haemost 103:1116-1127
17. Wienen W, Stassen JM, Priepke H, Ries UJ, Hauel N (2007) In vitro profile and ex vivo anticoagulant activity of the direct thrombin inhibitor dabigatran and its orally active prodrug, dabigatran etexilate. Thromb Haemost 98:155-162 (Pubitemid 47078782)
18. Sanford M, Plosker GL (2008) Dabigatran etexilate. Drugs 68:1699-1709
19. Stangier J, Rathgen K, Stähle H, Gansser D, Roth W (2007) The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects. Br J Clin Pharmacol 64:292-303 (Pubitemid 47283865)
20. Lindhout T, Blezer R, Hemker HC (1990) The anticoagulant mechanism of action of recombinant hirudin (CGP 39393) in plasma. Thromb Haemost 64:464-468
21. Al Dieri R, Alban S, Béguin S, Hemker HC (2004) Thrombin generation for the control of heparin treatment, comparison with the activated partial thromboplastin time. J Thromb Haemost 2:1395-1401 (Pubitemid 40186137)
22. Robert S, Ghiotto J, Pirotte B, David JL, Masereel B, Pochet L, Dogné JM (2009) Is thrombin generation the new rapid, reliable and relevant pharmacological tool for the development of anticoagulant drugs? Pharmacol Res 59:160-166
23. Cimenti C, Koestenberger M, Leschnik B, Haidl H, Muntean W (2007) The respective and combined anticoagulant effects of recombinant human activated protein C, melagatran and heparins using CAT. Thromb Res 119:361-367 (Pubitemid 44918099)
24. Bostrom SL, Hansson GF, Sarich TC, Wolzt M (2004) The inhibitory effect of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, compared with enoxaparin and r-hirudin on ex vivo thrombin generation in human plasma. Thromb Res 113:85-91 (Pubitemid 38481675)